Publications by authors named "Esteban Ribera"

Claim this Profile
E
Efficacy and safety of hydroxychloroquine in healthcare professionals with mild SARS-CoV-2 infection: Prospective, non-randomized trial.
Antonia Agusti, Elena Guillen, Alfonso Ayora, Andres Anton, Cristina Aguilera, Esteban Ribera

Enferm Infecc Microbiol Clin (Engl Ed)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV.
Ramón Teira, Helena Diaz-Cuervo, Filipa Aragão, Sophie Marguet, Belén de la Fuente, Esteban Ribera

PLoS One· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late presentation for HIV impairs immunological but not virological response to antiretroviral treatment.
Marta Rava, Otilia Bisbal, Lourdes Domínguez-Domínguez, Ma Remedios Aleman, María Rivero, Esteban Ribera

AIDS· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for asymptomatic STIs in HIV-infected men who have sex with men.
Rein Willekens, Irene Sánchez, Lucía Miguel, Juliana Esperalba, Judit Serra-Pladevall, Esteban Ribera

Sex Transm Infect· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of hydroxychloroquine in healthcare professionals with mild SARS-CoV-2 infection: Prospective, non-randomized trial.
Antonia Agusti, Elena Guillen, Alfonso Ayora, Andres Anton, Cristina Aguilera, Esteban Ribera

Enferm Infecc Microbiol Clin (Engl Ed)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of malignancy in a Spanish cohort of patients infected by the human immunodeficiency virus.
Esperanza Cañas-Ruano, Mario Martín-Castillo, Berta Raventós, Joaquín Burgos, Adrià Curran, Esteban Ribera

Med Clin (Barc)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of boosted darunavir plus rilpivirine in patients with long-lasting HIV-1 infection: DARIL study.
Jordi Navarro, Ana González-Cordón, José Luís Casado, Jose I Bernardino, Pere Domingo, Esteban Ribera

J Antimicrob Chemother· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipidomics Reveals Reduced Inflammatory Lipid Species and Storage Lipids after Switching from EFV/FTC/TDF to RPV/FTC/TDF: A Randomized Open-Label Trial.
Adrian Curran, Anna Rull, Jordi Navarro, Judit Vidal-González, Mario Martin-Castillo, Esteban Ribera

J Clin Med· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab.
Carla Serra-Peinado, Judith Grau-Expósito, Laura Luque-Ballesteros, Antonio Astorga-Gamaza, Jordi Navarro, Esteban Ribera

Nat Commun· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations.
Judith Grau-Expósito, Laura Luque-Ballesteros, Jordi Navarro, Adrian Curran, Joaquin Burgos, Esteban Ribera

PLoS Pathog· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Dual Combination of Dolutegravir-Rilpivirine for Switching to Maintenance Antiretroviral Therapy.
Esteban Ribera

AIDS Rev· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Once/Day Dolutegravir Plus Boosted Darunavir as a Switch Strategy in Heavily Treated Patients with Human Immunodeficiency Virus.
Jordi Navarro, José Ramón Santos, Ana Silva, Joaquin Burgos, Vicenç Falcó, Esteban Ribera

Pharmacotherapy· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiretroviral Therapy in Advanced HIV Disease: Which is the Best Regimen?
Joaquin Burgos, Esteban Ribera, Vicenç Falcó

AIDS Rev· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic impact of optimising antiretroviral treatment in human immunodeficiency virus-infected adults with suppressed viral load in Spain, by implementing the grade A-1 evidence recommendations of the 2015 GESIDA/National AIDS Plan.
Esteban Ribera, José Manuel Martínez-Sesmero, Javier Sánchez-Rubio, Rafael Rubio, Juan Pasquau

Enferm Infecc Microbiol Clin (Engl Ed)· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of darunavir/cobicistat and etravirine alone and co-administered in HIV-infected patients.
José Moltó, Adrian Curran, Cristina Miranda, Elizabeth Challenger, José Ramón Santos, Esteban Ribera

J Antimicrob Chemother· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute leg ischaemia in an HIV-infected patient receiving antiretroviral treatment.
Jordi Navarro, Adrian Curran, Joaquin Burgos, Ariadna Torrella, Inma Ocaña, Esteban Ribera

Antivir Ther· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial.
Federico Pulido, Esteban Ribera, María Lagarde, Ignacio Pérez-Valero, Rosario Palacios

Clin Infect Dis· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiological trends of HIV-1 infection in blood donors from Catalonia, Spain (2005-2014).
Marta Bes, Maria Piron, Natàlia Casamitjana, Josep Gregori, Juan Ignacio Esteban, Esteban Ribera

Transfusion· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4 T cells as a Major Niche for HIV-1 Transcription in HIV-Infected Patients.
Judith Grau-Expósito, Carla Serra-Peinado, Lucia Miguel, Jordi Navarro, Adrià Curran, Esteban Ribera

mBio· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study.
Jesús Troya, Pablo Ryan, Esteban Ribera, Daniel Podzamczer, Victor Hontañón

PLoS One· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atherogenic properties of LDL particles after switching from Truvada or Kivexa plus lopinavir/r to lamivudine plus lopinavir/r: OLE-MET substudy.
Maria Saumoy, Juan M Tiraboschi, Jordi Ordoñez-Llanos, Esteban Ribera, Pere Domingo

HIV Clin Trials· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study.
Jesús Troya, Pablo Ryan, Esteban Ribera, Daniel Podzamczer, Victor Hontañón

PLoS One· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of an abacavir/lamivudine + rilpivirine regimen for the treatment of HIV-1 infection in naive patients.
Adrian Curran, Jhon Rojas, Alfonso Cabello, Jesús Troya, Arkaitz Imaz, Esteban Ribera

J Antimicrob Chemother· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.
José Antonio Iribarren, Rafael Rubio, Koldo Aguirrebengoa, Jose Ramón Arribas, Josu Baraia-Etxaburu, Esteban Ribera

Enferm Infecc Microbiol Clin· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.
José Antonio Iribarren, Rafael Rubio, Koldo Aguirrebengoa, Jose Ramón Arribas, Josu Baraia-Etxaburu, Esteban Ribera

Enferm Infecc Microbiol Clin· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis